COMPANY

Concerto Biosciences

HQ: Cambridge, MA source · concertobio.com ↗ · New England

Location: Cambridge, MA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Atopic Dermatitis Atopic Dermatitis Eczema vulvovaginal candidiasis ENS-002

Timeline

Sep 18, 2024 Trial start Phase 1: Topical ENS-002 for Atopic Dermatitis in Adults source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT06469385	Topical ENS-002 for Atopic Dermatitis in Adults	Phase 1	Terminated	Sep 18, 2024	Aug 4, 2025 (actual)

Annual award amounts. Total $300K.

Jun 29, 2022 NIH award 1R43AI167131-01 FY2022: $299,907 awarded for that fiscal year; activity R43 (SBIR); PI KEHE, JARED SCOTT; recipient as written: CONCERTO BIOSCIENCES, CAMBRIDGE, MA. Discovery of bacterial consortia to treat source ↗